Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II.
暂无分享，去创建一个
A. Schally | K. Groot | K. Szepesházi | A. Jungwirth | M. Vadillo-Buenfil | G. Halmos | R. Cai | G. Galvan | J. Pinski | G. Galván | Georg Galvan | R. Z. Gai